Filing Flows › Cue Biopharma (CUE) › Q2 2026 › vs Q2 2025
Cue Biopharma (CUE) Q2 2026 vs Q2 2025 (year over year)
Cue Biopharma's revenue rose $4.9M (+167%) from $3.0M in Q2 2025 to $7.9M in Q2 2026.
Cue Biopharma, Q2 2026: revenue $7.9M (+167% year over year), net loss $153M, operating cash flow −$29.0M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $7.9M | $3.0M | $4.9M | +167% |
| Net loss | $153M | $8.5M | $145M | 18× |
| Costs & expenses | $161M | $11.6M | $149M | 14× |
| Operating costs | $95.6M | $11.6M | $84.0M | +725% |
| Interest & other, net | $65.4M | −$153K | $65.5M | — |
| Research & development | $49.0M | $7.9M | $41.1M | +520% |
| General & admin | $46.6M | $3.7M | $42.9M | 13× |
| Operating cash sources | $153M | $8.5M | $145M | 18× |
| Depreciation & amortization | $36K | $99K | −$63K | -64% |
| Share-based compensation | $23.8M | $1.3M | $22.6M | 19× |
| Working capital & other | $100M | $3.7M | $96.5M | 27× |
| Cash used in operations | $29.0M | $3.4M | $25.6M | +749% |
| Net loss absorbed | $153M | $8.5M | $145M | 18× |
Questions
How much did Cue Biopharma's revenue grow year over year in Q2 2026?
Cue Biopharma's revenue rose $4.9M (+167%) from $3.0M in Q2 2025 to $7.9M in Q2 2026.